261 related articles for article (PubMed ID: 36851192)
1. A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis.
Mohamed MS; Mohamed AO; Alenazy R; Khan YH; Idriss MT; Alhudaib NAA; Elsaman T; Mohamed MA; Eltayib EM; Mallhi TH
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851192
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.
Mallhi TH; Khan YH; Butt MH; Salman M; Tanveer N; Alotaibi NH; Alzarea AI; Alanazi AS
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557002
[TBL] [Abstract][Full Text] [Related]
3. Self-reported side effects of COVID-19 vaccines among health professions students in India.
Majumder MAA; Bharatha A; Kumar S; Chatterjee M; Gupta S; Harewood H; Singh K; Johnson W; Rajasundaram A; Dutta SB; Prasad SV; Rahman S; Kabir R; Parsa AD; Gaur U; Rabbi AMF; Krishnamurthy K; Mohammad S; Chode V; Haque M; Campbell MH
PeerJ; 2024; 12():e17083. PubMed ID: 38590705
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.
Luk TT; Lui JHT; Wang MP
J Med Internet Res; 2022 Oct; 24(10):e39063. PubMed ID: 36179132
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
7. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications.
Mustafa ZU; Maqbool F; Wahid M; Salman M; Haroon S; Khan YH; Mallhi TH; Godman B
Rev Soc Bras Med Trop; 2023; 56():e0044. PubMed ID: 37283345
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
11. The Side Effects of COVID-19 Vaccines and Its Association With ABO Blood Type Among the General Surgeons in Saudi Arabia.
Alessa MY; Aledili FJ; Alnasser AA; Aldharman SS; Al Dehailan AM; Abuseer HO; Almohammed Saleh AA; Alsalem HA; Alsadiq HM; Alsultan AS
Cureus; 2022 Mar; 14(3):e23628. PubMed ID: 35494934
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Side Effects of the AstraZeneca COVID-19 Vaccine: A Multicenter Experience From Pakistan.
Haider T; Ali J; Ali SM; Iftikhar AS; Siddiqui AA; Khan AS; Qamar JA; Sohail K; Anwar A; Hashmi AA
Cureus; 2023 Oct; 15(10):e46543. PubMed ID: 37927680
[TBL] [Abstract][Full Text] [Related]
13. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
Rababa'h AM; Abedalqader NN; Ababneh M
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Adverse Effects Following Booster Dose of Inactivated-Virus vs. Adenoviral-Vector COVID-19 Vaccines in Algeria: A Cross-Sectional Study of the General Population.
Lounis M; Aouissi HA; Abdelhadi S; Rais MA; Belkessa S; Bencherit D
Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366290
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Adverse Effects Immediately after the Start of COVID-19 Booster Vaccination in Vietnam.
Nguyen DC; Dao TL; Truong TMD; Nguyen TH; Phan TN; Nguyen HM; Pham TD; Nguyen XB; Nguyen TB; Hoang VT
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016213
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
[TBL] [Abstract][Full Text] [Related]
17. A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
Hassan YAM; Daud Ali M; Al-Eid RR; Al-Ghuraya FA; Essa Alqasimi Z; Ahmad A; Eltrafi Z; Ghosn SA
Vaccine; 2022 Nov; 40(49):7087-7096. PubMed ID: 36404426
[TBL] [Abstract][Full Text] [Related]
18. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population.
Elgendy MO; El-Gendy AO; Mahmoud S; Mohammed TY; Abdelrahim MEA; Sayed AM
Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062770
[TBL] [Abstract][Full Text] [Related]
19. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants.
Abouzid M; Ahmed AA; El-Sherif DM; Alonazi WB; Eatmann AI; Alshehri MM; Saleh RN; Ahmed MH; Aziz IA; Abdelslam AE; Omran AA; Omar AA; Ghorab MA; Islam SMS
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Short-Term Safety of COVID-19 Vaccines: A Cross-Sectional Study on Vaccinated People in the UAE.
AlHamaidah MA; Noureldin N; Yehia A; Alani I; Al-Qussain A; Abdou O; Ashames A; Kharaba Z
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
